Association of apolipoproteins A1 and B with type 2 diabetes and fasting blood glucose: a cross-sectional study

BMC Endocrine Disorders

Table 4 Mean FBG level according to quartiles of ApoA1, ApoB levels and ApoB/A1 ratio

Variables	Quartiles by Apolipoproteins				p-Diff	p-Trend
Variables	Q1	Q2	Q3	Q4	p-Diff	p-Trend
ApoA1
n	255	257	257	258
FBG, mmol/L
Model 1	6.891 ± 0.113	5.316 ± 0.113^**	5.636 ± 0.113^**	5.802 ± 0.113^**#	< 0.001	< 0.001
Model 2	6.067 ± 0.078	5.574 ± 0.074^**	5.881 ± 0.074^#	6.117 ± 0.074^##	< 0.001	0.184
Model 3	6.067 ± 0.078	5.575 ± 0.074^**	5.880 ± 0.075^#	6.117 ± 0.074^##	< 0.001	0.184
ApoB
n	262	252	260	253
FBG, mmol/L
Model 1	5.637 ± 0.117	5.842 ± 0.119	6.136 ± 0.117^*	6.026 ± 0.119	0.017	0.006
Model 2	5.728 ± 0.074	5.914 ± 0.075	6.087 ± 0.074^*	5.910 ± 0.075	0.009	0.034
Model 3	5.730 ± 0.075	5.914 ± 0.075	6.087 ± 0.074^*	5.908 ± 0.076	0.010	0.038
ApoB/A1 ratio
n	256	257	258	256
FBG, mmol/L
Model 1	5.622 ± 0.115	5.787 ± 0.114	5.419 ± 0.114	6.814 ± 0.114^**#¶	< 0.001	< 0.001
Model 2	5.906 ± 0.076	5.972 ± 0.074	5.679 ± 0.075^#	6.083 ± 0.077^¶	0.002	0.499
Model 3	5.910 ± 0.077	5.971 ± 0.074	5.678 ± 0.075^#	6.080 ± 0.078^¶	0.002	0.533

Model 1 was adjusted for age. Model 2 was adjusted for sex, age, BMI, education, marriage, exercise, cigarette smoking, alcohol consumption and hypoglycemic drugs use. Model 3 further adjusted for lipid-lowering drugs use
Apo apolipoprotein, FBG fasting blood glucose, Q quartile. p-Diff: Multiple comparison among quartiles
^*p < 0.05 compared with Q1
^**p < 0.001 compared with Q1
^#p < 0.05 compared with Q2
^##p < 0.001compared with Q2
^¶p < 0.05 compared with Q3

ISSN: 1472-6823